# Exploring the Anxiolytic Effects of Selank on Brain Connectivity

Canonical source: https://retacompare.com/research/exploring-the-anxiolytic-effects-of-selank-on-brain-connectivity

Cognitive & Nootropic · 2020-01-01


    Selank demonstrates significant effects on brain connectivity related to anxiety regulation. This peptide, known for its anxiolytic properties, has been the subject of research aimed at understanding its impact on brain function. The study in question utilized advanced neuroimaging techniques to explore how Selank influences resting-state functional connectivity in healthy individuals.

 What this study examined

The study assessed the effects of Selank and another peptide, Semax, on the whole-brain resting-state functional connectivity (FC) in a cohort of 52 healthy participants. Researchers conducted resting-state fMRI scans at three intervals: before the injection and then at 5 and 20 minutes post-injection of either Selank, Semax, or a placebo. The primary regions of interest included the amygdala, crucial for anxiety regulation, and the dorsolateral prefrontal cortex (DLPFC), which is vital for executive functions such as working memory.

 Why it matters for Selank research

This study is significant as it provides insights into the neural mechanisms underlying the anxiolytic effects of Selank. By focusing on functional connectivity changes in specific brain regions, the research enhances understanding of how Selank may modulate anxiety-related neural pathways. The findings contribute to a growing body of evidence supporting the therapeutic potential of Selank in treating anxiety disorders, offering a foundation for future studies that may explore its clinical applications.

 Key findings

Selank and Semax were assessed for their effects on resting-state functional connectivity.

Functional connectivity was analyzed between the right amygdala and various regions in the right hemisphere.

Significant differences in functional connectivity were observed between the treatment and placebo groups.

Post hoc analysis identified both general and specific effects of Selank on brain connectivity.

The study highlighted the relationship between the right amygdala and the right temporal cortex.

 How Selank works (background)

Selank is a synthetic peptide derived from the naturally occurring peptide tuftsin, known for its immunomodulatory and anxiolytic properties. It acts primarily on the central nervous system, influencing neurotransmitter systems such as serotonin and dopamine, which are critical in mood regulation and anxiety response. Selank's mechanism involves enhancing the expression of brain-derived neurotrophic factor (BDNF), which supports neuronal health and plasticity. This modulation of neurotrophic factors may lead to improved cognitive functions and reduced anxiety, making Selank a subject of interest in neuropsychopharmacology.

 Practical takeaways for researchers

Researchers investigating Selank should consider the implications of its effects on brain connectivity, particularly in relation to anxiety and cognitive functions. The findings from this study suggest that Selank may offer a unique approach to modulating neural pathways associated with anxiety. Future research could expand on these insights by exploring dose-response relationships, long-term effects, and potential applications in clinical settings. Additionally, understanding the specific brain regions affected by Selank may guide the development of targeted therapies for anxiety disorders.

 FAQ

 What is Selank used for?

Selank is primarily researched for its anxiolytic effects and potential cognitive-enhancing properties.

 How does Selank differ from Semax?

While both are peptides with neuroprotective effects, Selank is mainly focused on anxiety reduction, whereas Semax is noted for its nootropic effects.

 Are there any side effects associated with Selank?

Current research indicates that Selank has a favorable safety profile, but further studies are needed to fully understand its long-term effects.

 Source: PubMed · Dokl Biol Sci · published 2020-01-01.

## Sources

- PubMed · Dokl Biol Sci: https://pubmed.ncbi.nlm.nih.gov/32342318/